Chimerix Inc (CMRX)
1.02
+0.03
(+3.03%)
USD |
NASDAQ |
Nov 05, 11:30
Chimerix Cash from Operations (Quarterly): -17.68M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -17.68M |
| March 31, 2024 | -17.52M |
| December 31, 2023 | -14.59M |
| September 30, 2023 | -17.93M |
| June 30, 2023 | -14.34M |
| March 31, 2023 | -22.22M |
| December 31, 2022 | -19.99M |
| September 30, 2022 | 7.128M |
| June 30, 2022 | -10.56M |
| March 31, 2022 | -23.45M |
| December 31, 2021 | -34.02M |
| September 30, 2021 | -15.29M |
| June 30, 2021 | -12.72M |
| March 31, 2021 | -37.90M |
| December 31, 2020 | -9.045M |
| September 30, 2020 | -8.299M |
| June 30, 2020 | -7.874M |
| March 31, 2020 | -10.82M |
| December 31, 2019 | -3.469M |
| September 30, 2019 | -42.16M |
| June 30, 2019 | -13.82M |
| March 31, 2019 | -15.73M |
| December 31, 2018 | -8.30M |
| September 30, 2018 | -12.88M |
| June 30, 2018 | -14.04M |
| Date | Value |
|---|---|
| March 31, 2018 | -18.51M |
| December 31, 2017 | -12.12M |
| September 30, 2017 | -11.38M |
| June 30, 2017 | -13.00M |
| March 31, 2017 | -13.62M |
| December 31, 2016 | -9.697M |
| September 30, 2016 | -12.93M |
| June 30, 2016 | -12.55M |
| March 31, 2016 | -28.64M |
| December 31, 2015 | -32.92M |
| September 30, 2015 | -24.93M |
| June 30, 2015 | -23.02M |
| March 31, 2015 | -18.84M |
| December 31, 2014 | -16.87M |
| September 30, 2014 | -11.45M |
| June 30, 2014 | -9.637M |
| March 31, 2014 | -9.116M |
| December 31, 2013 | -6.785M |
| September 30, 2013 | -5.144M |
| June 30, 2013 | -7.585M |
| March 31, 2013 | -6.045M |
| December 31, 2012 | -4.649M |
| September 30, 2012 | 12.36M |
| June 30, 2012 | -4.68M |
| March 31, 2012 | -4.907M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-37.90M
Minimum
Mar 2021
7.128M
Maximum
Sep 2022
-15.29M
Average
-14.59M
Median
Dec 2023
Cash from Operations (Quarterly) Benchmarks
| SIGA Technologies Inc | 5.953M |
| Abbott Laboratories | 2.705B |
| Emergent BioSolutions Inc | 47.50M |
| Tonix Pharmaceuticals Holding Corp | -9.919M |
| Geovax Labs Inc | -1.941M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 14.36M |
| Cash from Financing (Quarterly) | -0.042M |
| Free Cash Flow | -67.84M |
| Free Cash Flow Per Share (Quarterly) | -0.1981 |
| Free Cash Flow to Equity (Quarterly) | -17.75M |
| Free Cash Flow Yield | -74.64% |